Familial Milroy lymphedema (ML) is classified as an autosomal dominant diso
rder characterized by peripheral edema of the lower extremities at birth or
in early childhood. The variety of phenotypes are not well described, and
the genomic location and functional expression of the gene or genes underly
ing this and related familial lymphedema syndromes remain largely unknown.
In this collaborative study between the University of Arizona and the Unive
rsity of Sao Paulo, we collected clinical pedigrees on 6 ML families, carri
ed out clinical examination of affected and unaffected individuals, and in
representative affected members of two of the families performed dynamic ly
mphangioscintigraphy (LAS) of the lower and upper limbs to delineate furthe
r the ML lymphangiodysplastic phenotype. To localize the gene for ML, we co
nducted a genome-wide search in 4 of the families using 387 polymorphic din
ucleotide-repeat markers at approximate 10 cM spacing in 54 subjects (affec
ted, unaffected bloodline relatives, and spouses). In all 6 families (86 su
bjects), we specifically examined the suggested linkage to the vascular end
othelial growth factor (VEGF)-C receptor (Flt4) gene localized to the chrom
osome region 5q34-q35, The findings provide evidence for a spectrum of ML c
linical and LAS phenotypes and also suggest ML locus heterogeneity.